Similarly, in the ER+/HER2-overexpressing BT-474 human BC cell line, genistein and tamoxifen monotherapy significantly increased the G1 phase cell population, and this G1 arrest effect was enhanced when the two molecules were used in combination [214]. This evidence concerns the gene ERBB2 and breast cancer.